Swapnil Malekar

Swapnil Malekar, PhD, MBA, is currently the Director of Corporate Ventures at AstraZeneca and serves as a Board Observer at Asher Biotherapeutics. With a robust background in biotechnology equity research, Swapnil has held significant positions at notable firms including Piper Sandler and Barclays. Prior to these roles, they worked as a Senior Scientist at Novartis Institutes for BioMedical Research and gained valuable experience as a Formulation Scientist at Teva Pharmaceuticals. Their academic credentials include a Doctor of Philosophy in Pharmaceutics and Drug Design, along with a Master of Science in Industrial Pharmacy and Pharmaceutics.